Insilico Medicine, the biotech company with twin headquarters in Boston and Hong Kong, said it’s the first time an AI-created ...

Prominent speakers from companies such as Microsoft, the UK Health Security Agency, AltruBio Inc., Axia Medicine, AstraZeneca, Eli Lilly and Company, Roche, MENARINI Group, Deep Science Ventures etc.

Researchers led by Rice University's Benjamin J. Fregly have developed treatment design software that implements a novel personalized medicine approach for addressing this important societal problem.

India Inc's Q4 earnings season intensifies with 81 firms, including ITC, Sun Pharma, ONGC, and Hindalco, set to report this week, offering insights into sectoral performance and future growth outlooks ...

Antisolvent precipitation aided by polymeric additives has increasingly been explored as a method to produce micron-sized/submicron particles of active pharmaceutical ingredients with low aqueous ...

Their responses insult those investors’ intelligence. On Wednesday, we got a doozy from Mayne Pharma, an ASX 300 drug company big enough and listed for long enough to know better. Despite ...

(NewsNation) — For scientists, space could be the new frontier of medicine, particularly when it comes to ... so scientists on the ground develop pharmaceutical predictions and test them by sending ...

Monash School of Public Health and Preventive Medicine (SPHPM) and the Personal Injury Education ... of the policy rationale and parameters governing personal injury scheme design. The centrepiece of ...

Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing ... Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates from ...

The pharmaceutical industry in Ireland was last night trying to work out the potential impact of US President Donald Trump’s vow to force European countries to pay higher drug prices while ...

While the move may offer immediate relief to American patients, it is likely to trigger a global price recalibration with pharmaceutical giants intensifying pressure on lower-cost markets like ...

Stylus Medicine Inc., a biotechnology company dedicated to developing transformative in vivo genetic medicines, has emerged from stealth with $85 million in financing to advance its in vivo genetic ...